
In this area our teams are elucidating the biochemical and cellular basis of human diseases and the molecular mechanisms underlying drug action and their targets.
Our investigation of disease mechanisms provides insights into identification of novel therapeutic targets for which small molecules or biologics are being developed. Research is directed towards the molecular and cellular mechanisms underlying the function of therapeutic targets, correcting the target using gene therapy, and the intracellular signalling pathways they control and the mechanistic study of drug action. Approaches incorporate human studies, patient-derived samples and animal models of disease. Our research teams are interested in several human diseases or conditions including drug addiction, autism, diabetes, cancer, genetic disorders, infectious diseases, and neurological diseases.
Investigators
Research News
Image

Faces of PharmSci: Mahya Rezaeifarimani
Supervised by Prof. Shirley Wu, PhD student Mahya Rezaeifarimani is developing smart nanoparticles to help make radiation therapy work better for brain tumours by targeting low-oxygen areas that often make treatment less effective.
Read More
Image

Dean Lisa Dolovich reappointed for second term
Professor Lisa Dolovich has been reappointed for a second term as Dean of the Leslie Dan Faculty of Pharmacy, University of Toronto, effective July 1, 2025, to December 30, 2030.
Read More
Image

Pharmacy Summer Camp gives high school students insight into pharmacy profession
A new summer camp based at the faculty will give high school students a range of experiences in pharmacy and pharmaceutical sciences.
Read More